Skip to content

Transactions

Sichenzia Ross Ference Carmel LLP Represents High Roller Technologies, Inc. in $25 Million Registered Direct Offering

January 22, 2026

Sichenzia Ross Ference Carmel LLP Represents BriaCell Therapeutics in $30 Million Public Offering

January 15, 2026

Sichenzia Ross Ference Carmel LLP Represents Aegis Capital Corp. in $8 Million Registered Direct Offering and Private Placement of Estrella Immunopharma

January 8, 2026

Sichenzia Ross Ference Carmel LLP Represents Dominari Securities and American Ventures in $20 Million ELOC and $3 Million Private Placement of MMA.INC

January 6, 2026

Sichenzia Ross Ference Carmel LLP Represents Lixte Biotechnology in $4.3 Million Registered Direct Offering

December 19, 2025

Sichenzia Ross Ference Carmel LLP Represents D. Boral Capital in $20 Million Underwritten Public Offering of Aduro Clean Technologies

December 19, 2025

Sichenzia Ross Ference Carmel LLP Represents D. Boral Capital in Financing Arrangements for Up to $180 Million of Robo.ai Inc.

December 19, 2025

Sichenzia Ross Ference Carmel LLP Represents Avalon GloboCare in its Acquisition of RPM Interactive

December 17, 2025

Sichenzia Ross Ference Carmel LLP Represents Jiuzi Holdings in $4 Million Registered Direct Offering

December 17, 2025

Sichenzia Ross Ference Carmel LLP Represents Lexaria Bioscience Corp. in $3.5 Million Registered Direct Offering

December 17, 2025

Sichenzia Ross Ference Carmel LLP Represents Treasure Global in $2.5 Million Registered Direct Offering

December 15, 2025

Sichenzia Ross Ference Carmel LLP Represents Virax Biolabs Group Limited in $5 Million Private Placement

December 9, 2025

Sichenzia Ross Ference Carmel LLP Represents JonesTrading in $100 Million At-the-Market Offering of Armata Pharmaceuticals

December 8, 2025

Sichenzia Ross Ference Carmel LLP Represents RBW Capital Partners in $113.5 Million Private Placement of SMX

December 4, 2025

Sichenzia Ross Ference Carmel LLP Represents FibroBiologics, Inc., in $1.5 Million Registered Direct Offering and Concurrent Private Placement

December 2, 2025

Sichenzia Ross Ference Carmel LLP Represents FibroBiologics, Inc., in $4 Million Registered Direct Offering and Concurrent Private Placement with Purchase Price Paid in Gold

December 2, 2025

Sichenzia Ross Ference Carmel LLP Represents LIXTE Biotechnology in its Acquisition of Liora Technologies

November 26, 2025

Sichenzia Ross Ference Carmel LLP Represents Healthcare Triangle in Up to $20 Million At-the-Market Offering

November 26, 2025

Sichenzia Ross Ference Carmel LLP Represents Soulpower Acquisition Corporation in $8.1 Billion Business Combination with SWB LLC to Establish SOUL WORLD BANK

November 25, 2025

Sichenzia Ross Ference Carmel LLP Represents Dominari Securities and Madison Global Partners in $3.675 Million Registered Direct Offering of authID

November 24, 2025

Sichenzia Ross Ference Carmel LLP Represents Institutional Investor in Financing Arrangements for Up to $20 Million of Ensysce Biosciences

November 18, 2025